Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

BACKGROUND: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirjačić Martinović, Katarina, Vuletić, Ana, Tišma Miletić, Nevena, Besu Žižak, Irina, Milovanović, Jelena, Matković, Suzana, Jurišić, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579527/
https://www.ncbi.nlm.nih.gov/pubmed/37806113
http://dx.doi.org/10.1016/j.tranon.2023.101799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579527/
https://www.ncbi.nlm.nih.gov/pubmed/37806113
http://dx.doi.org/10.1016/j.tranon.2023.101799

Ejemplares similares